Found: 6
Select item for more details and to access through your institution.
Safety and Efficacy of Lebrikizumab in Adolescent Patients with Moderate-to-Severe Atopic Dermatitis: A 52-Week, Open-Label, Phase 3 Study.
- Published in:
- Dermatology & Therapy, 2023, v. 13, n. 7, p. 1517, doi. 10.1007/s13555-023-00942-y
- By:
- Publication type:
- Article
619 - Lebrikizumab improves signs and symptoms of moderate-to-severe atopic dermatitis in patients not adequately controlled or non-eligible for cyclosporine: a placebo-controlled, randomized phase 3 clinical study (ADvantage).
- Published in:
- British Journal of Dermatology, 2024, v. 191, p. 1, doi. 10.1093/bjd/ljae266.005
- By:
- Publication type:
- Article
The Quail Mesonephros: A New Model for Renal Senescence?
- Published in:
- Journal of Vascular Research, 2006, v. 43, n. 6, p. 581, doi. 10.1159/000096076
- By:
- Publication type:
- Article
Morphological characterization of pecteneal hyalocytes in the developing quail retina.
- Published in:
- Journal of Anatomy, 2009, v. 215, n. 3, p. 280, doi. 10.1111/j.1469-7580.2009.01117.x
- By:
- Publication type:
- Article
Carbohydrate characterization of quail primordial germ cells during migration and gonadal differentiation.
- Published in:
- Journal of Anatomy, 2007, v. 210, n. 1, p. 98, doi. 10.1111/j.1469-7580.2006.00668.x
- By:
- Publication type:
- Article
β-Catenin expression during vascular development and degeneration of avian mesonephros.
- Published in:
- Journal of Anatomy, 2005, v. 206, n. 2, p. 165, doi. 10.1111/j.1469-7580.2005.00382.x
- By:
- Publication type:
- Article